While the overall results across studies are inconsistent, a clinical study on patients with RA under methotrexate therapy revealed increased TIMP1 and MMP8 concentrations in blood of individuals with RA and periodontal inflammation, indicating an immunologic dysbalance of these patients [42]. This evidence concerns the gene MMP8 and rheumatoid arthritis.